Alabama Academy of Family Physicians
MAY 15, 2025
The 2025 Alabama Legislative Session concluded on May 14 at midnight. These funds could be utilized for various purposes, including direct care, operational expenses, and facility maintenance or upgrades. What Happened: The bill was signed into law by the Governor on 4/15/2025.
My Green Doctor
MAY 3, 2025
That’s why our Practice Management program includes a guided, meeting-by-meeting path for helping clinics transition to renewable energy and cut utility bills—without overwhelming staff or adding to your to-do list. The product manufacturers and vendors will need to be active partners as well. Looking for a tailored approach?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Alabama Academy of Family Physicians
FEBRUARY 19, 2025
As the 2025 legislative session swings into full gear, the Alabama Academy of Family Physicians (AAFP) has set its sights on a cadre of pivotal bills set to shape the healthcare landscape for years to come. These funds could be utilized for various purposes, including direct care, operational expenses, and facility maintenance or upgrades.
FDA Law
JULY 17, 2022
Currently, a health care provider identifies any discarded quantity from such a vial in the claim using a JW modifier, and Medicare Part B pays for both the utilized and the discarded amount. The manufacturer responsible for paying the refunds will be the company whose NDC is on the label.
Physician's Practice
JUNE 9, 2025
of Roetzel & Andress June 9, 2025 By Austin Littrell Fact checked by Keith A. Financial Relationships with Pharmaceutical Companies (00:20:10)** Legal and ethical concerns for physicians with financial ties to GLP-1 drug manufacturers, including anti-kickback laws. Austin Littrell June 2nd 2025 Podcast Tom Price, M.D.,
FDA Law
SEPTEMBER 20, 2021
Notable Dates and Timelines – Program opens, beginning of FY 2023; Expediting reviews fully implemented, by FY 2024; Webpage with detailed criteria for acceptance and participation, October 1, 2022; Interim assessment, end of FY 2025; Public workshop, end of Q2 FY 2026. Notable Dates and Timelines – New MAPP published, by Dec.
FDA Law
AUGUST 14, 2022
The negotiations will result in a Maximum Fair Price (“MFP”) that the manufacturer must make available to providers furnishing the drug under Medicare Part B or pharmacies dispensing the drug under Part D. that price controls distort markets and reduce competition.
Expert insights. Personalized for you.
130 
Let's personalize your content